Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-13
DOI
10.1038/s41386-020-0706-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temporal dynamics of the pharmacological MRI response to subanaesthetic ketamine in healthy volunteers: A simultaneous EEG/fMRI study
- (2019) Rebecca McMillan et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia
- (2019) Ferdinando Nicoletti et al. Frontiers in Psychiatry
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review
- (2018) Ragy R. Girgis et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)
- (2018) A. Egerton et al. MOLECULAR PSYCHIATRY
- Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention
- (2018) J A Lieberman et al. MOLECULAR PSYCHIATRY
- Association between glutamate/glutamine and blood oxygen level dependent signal in the left dorsolateral prefrontal region during verbal working memory
- (2018) Anupa A. Vijayakumari et al. NEUROREPORT
- Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects
- (2018) Mitul A. Mehta et al. PSYCHOPHARMACOLOGY
- Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders
- (2018) Daniel C. Javitt et al. JAMA Psychiatry
- Direct neurophysiological evidence for a role of the human anterior cingulate cortex in central command
- (2018) Martin J. Gillies et al. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
- The application of positron emission tomography (PET) imaging in CNS drug development
- (2018) Ivonne Suridjan et al. Brain Imaging and Behavior
- Factors Influencing the Cardiovascular Response to Subanesthetic Ketamine: A Randomized, Placebo-Controlled Trial
- (2017) Thomas Liebe et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Neurophysiological Effects of Bitopertin in Schizophrenia
- (2017) Joshua T. Kantrowitz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Combined fMRI-MRS acquires simultaneous glutamate and BOLD-fMRI signals in the human brain
- (2017) I. Betina Ip et al. NEUROIMAGE
- Assessment of intra- and inter-regional interrelations between GABA+, Glx and BOLD during pain perception in the human brain – A combined 1 H fMRS and fMRI study
- (2017) Marianne Cleve et al. NEUROSCIENCE
- Glutamatergic, GABAergic, and endocannabinoid neurotransmissions within the dorsal hippocampus modulate the cardiac baroreflex function in rats
- (2017) Nilson Carlos Ferreira-Junior et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- mGluR2/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions
- (2016) L E Jin et al. MOLECULAR PSYCHIATRY
- Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia
- (2015) Bruce J. Kinon et al. BIOLOGICAL PSYCHIATRY
- Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
- (2015) Elias Mouchlianitis et al. SCHIZOPHRENIA BULLETIN
- The Selective Glycine Uptake Inhibitor Org 25935 as an Adjunctive Treatment to Atypical Antipsychotics in Predominant Persistent Negative Symptoms of Schizophrenia
- (2014) Joep H. Schoemaker et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Dissociable Effects of Antipsychotics on Ketamine-Induced Changes in Regional Oxygenation and Inter-Regional Coherence of Low Frequency Oxygen Fluctuations in the Rat
- (2014) Jennifer Li et al. NEUROPSYCHOPHARMACOLOGY
- Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings
- (2014) Eline M.P. Poels et al. SCHIZOPHRENIA RESEARCH
- Involvement of N-methyl- d -aspartate glutamate receptor and nitric oxide in cardiovascular responses to dynamic exercise in rats
- (2013) Laura H.A Camargo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver
- (2013) Scott A. Schobel et al. NEURON
- Sub-Anesthetic Ketamine Modulates Intrinsic BOLD Connectivity Within the Hippocampal-Prefrontal Circuit in the Rat
- (2013) Natalia Gass et al. NEUROPSYCHOPHARMACOLOGY
- Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers
- (2012) S. De Simoni et al. NEUROIMAGE
- The impact of “physiological correction” on functional connectivity analysis of pharmacological resting state fMRI
- (2012) Najmeh Khalili-Mahani et al. NEUROIMAGE
- Clinical development of pomaglumetad methionil: A non-dopaminergic treatment for schizophrenia
- (2012) Bruce J. Kinon et al. NEUROPHARMACOLOGY
- Glutamate modulates resting state activity in the perigenual anterior cingulate cortex – A combined fMRI–MRS study
- (2012) B. Enzi et al. NEUROSCIENCE
- 1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism
- (2011) Golam M.I. Chowdhury et al. BIOLOGICAL PSYCHIATRY
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
- (2011) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- 13C MRS studies of neuroenergetics and neurotransmitter cycling in humans
- (2011) Douglas L. Rothman et al. NMR IN BIOMEDICINE
- Awake Rat Pharmacological Magnetic Resonance Imaging as a Translational Pharmacodynamic Biomarker: Metabotropic Glutamate 2/3 Agonist Modulation of Ketamine-Induced Blood Oxygenation Level Dependence Signals
- (2010) C.-L. Chin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer's Disease: Selective Activation of mGlu2 Receptors Amplifies -Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective
- (2010) F. Caraci et al. MOLECULAR PHARMACOLOGY
- Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation
- (2010) E.A. Hackler et al. NEUROSCIENCE
- Regulation of Group II Metabotropic Glutamate Receptors by G Protein-Coupled Receptor Kinases: mGlu2 Receptors Are Resistant to Homologous Desensitization
- (2009) L. Iacovelli et al. MOLECULAR PHARMACOLOGY
- Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)
- (2008) M. J. Fell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Influence of heart rate on the BOLD signal: The cardiac response function
- (2008) Catie Chang et al. NEUROIMAGE
- Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat
- (2008) Alessandro Gozzi et al. PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now